Recent Stories and Publications Featuring VCCBH Members
Posted December 4, 2024
On November 16, Larner Assistant Professor of Medicine Debora Kamin Mukaz, Ph.D., M.S., moderated a panel on science policy advocacy titled “How can we engage scientists from historically underrepresented backgrounds in policymaking and advocacy?” at the American Heart Association’s Scientific Sessions 2024 conference in Chicago. The panelists were AHA President Keith Churchwell, M.D.; past AHA President Michelle Albert, M.D., M.P.H.; Emelia Benjamin, M.D., Sc.M., associate provost and professor of medicine and epidemiology at Boston University; and Carl Streed, Jr., M.D., M.P.H., associate professor of medicine at Boston University.
Posted December 3, 2024
Neurodegeneration in spider brain leads Vermont neuroscientists to groundbreaking discovery in Alzheimer’s-affected human brains
Vermont Business Magazine Researchers from Saint Michael’s College and the University
of Vermont have made a groundbreaking new discovery that provides a better understanding of how Alzheimer’s disease develops in the human brain.
Posted October 23, 2024
In a recent paper published in Nature Communications titled “Endothelial Piezo1 Channel Mediates Mechano-Feedback Control of Brain Blood Flow,” Osama Harraz, Ph.D., Bloomfield Early Career Professor in Cardiovascular Research
and assistant professor of pharmacology at the Robert Larner, M.D. College of Medicine, and his team of researchers from American and European institutions reveal that Piezo1, a lesser-understood protein, acts as a “brake”
system, helping blood flow return to normal after neural activity.
Posted October 23, 2024
Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin
concentration.
Posted October 23, 2024
The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early
childhood.
Posted October 16, 2024
Osama Harraz, Ph.D and his team of researchers at the University of Vermont’s Larner College of Medicine have made a breakthrough that could help in the effort to better understand the causes of dementia and how to stop it.
Posted October 14, 2024
REGARDS Study Grant Renewed: UVM’s Continued Contributions to Research on Stroke Disparities by Race and Geography. Investigators at the Larner College of Medicine are receiving a $10.1 million multi-year grant from the National
Institutes of Health (NIH) to continue their 23-year program studying stroke and cognitive disorders in the United States.
Posted October 2, 2024
Investigators at the Larner College of Medicine have received a $10.1 million multi-year grant from the National Institutes of Health to continue their work on the REGARDS project. The purpose of the project is to understand why those in some U.S.
regions develop more strokes and Alzheimer’s Disease and Related Dementia than others, and why Black people develop more strokes than white people.
Posted August 21, 2024
Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology, gave the Björn Folkow Lecture at the 15th Mechanisms of Vasodilation/Endothelium-Dependent Hyperpolarization (MOVD/EDH) 2024 conference July 2–5
at Magdalen College in Oxford, United Kingdom.